Health Plan Alliance Selects 1upHealth as Preferred Health Data Interoperability Partner

SSI Strategy and NDA Group Combine to Form Best-in-Class Global Life Sciences Consultancy

SSI Strategy has announced that it has entered into a definitive agreement to acquire NDA Group AB. This strategic combination will create a premier consultancy, specializing in guiding drug development companies from concept to commercialization.

ICS/ICB leaders Penny Dash and Paul Miller announced as speakers for the NHS Transformation Symposium

Mtech Access has announced that its annual NHS Transformation Symposium, this September, will feature guest speakers Penny Dash and Paul Miller, who hold strategic leadership roles in an Integrated Care Systemand Board, respectively.

Form Bio Announces First Half 2023 Achievements

Key Partnerships, Breakthrough Technology Advancement, Key Leadership Hires, and Industry Recognition Demonstrate Strong Success

RBQMLive, Sponsored by CluePoints, Wins Prestigious Sales and Marketing Award

RBQMLive, Sponsored by CluePoints, Wins Prestigious Sales and Marketing Award Two-day educational conference tops the experiential/event marketing category at the Sales and Marketing Technology Awards 2023

Phastar Appoints Graham Clark as New Chief Executive Officer

Phastar Appoints Graham Clark as New Chief Executive Officer Phastar Sets Course for Further Growth with New CEO Appointment

AI-Powered Healthcare: How Chatbots Are Transforming Healthcare

Healthcare chatbots are set to change how we look after our health. In the future, these digital helpers will talk more like humans, making it feel like chatting with a friend. They'll learn from each conversation, offering better advice over time. These chatbots will work alongside doctors, helping screen and understand patients' problems. They'll speak many languages, team up with gadgets like smartwatches to monitor our health, and be available 24/7. Plus, they'll remind us about medicines and appointments, keep our health data safe, and even help with emotional well-being. In short, they'll make healthcare more personal, easy, and accessible for everyone.

Click Therapeutics Launches Additional Randomized Clinical Study in Migraine, Conducted in Partnership with Syneos Health

Recent Cash Injection Boosts VectorBuilder to Unicorn Status

VectorBuilder's latest cash injection drives them towards a CDMO facility for the manufacturing of plasmids, mRNA, AAV, lentivirus, cell lines, and a variety of viral and non-viral vectors

Huateng Pharma Develops CAS NO.156-83-2 (Minoxidil Intermediate) Against Hair Loss

About Huateng Pharma Huateng Pharma is a global provider in contract development and manufacturing for intermediates. With our focus on operational excellence, and the integration of manufacturing operations with EHS, quality assurance, quality control, regulatory, supply chain management and project management, we can manufacture, scale-up and supply high-quality intermediates and APIs from our China facility. Contact us Hunan Huateng Pharmaceutical Co. Ltd. Address: Lugu Business Plaza E1, Yuelu District, Changsha City, Hunan Province, China Manufacturing Base: Tongguan Kiln, Wangcheng district, Changsha, Hunan, China Email: sales@huatengusa.com Website: https://us.huatengsci.com Zip code: 410205 Telephone: +86 731 89916275 Fax: +86 0731-82251112-818

ArisGlobal to Relocate Global Headquarters to Boston Area

ArisGlobal's move to the Greater Boston area reflects growth needs and geographically positions the life sciences SaaS provider among leading biopharmaceutical organizations.

Genedata Selector 9.0 Automates Critical Quality Attribute Assessment of Cell and Gene Therapy Products

Lactabico Joins Biolabs Heidelberg, Establishes EU Presence

The Lactocore Group has joined BioLabs Heidelberg, marking a significant expansion in the European Union of innovative research and development in the field of peptide therapy for the treatment of depression, anxiety and metabolic disorders.

Bora Pharmaceuticals unveils eye-opening new facility for Ophthalmic manufacturing

SYGNATURE DISCOVERY ACCELERATES GLOBAL GROWTH WITH MAJOR NORTH AMERICAN ACQUISITION

Leading integrated drug discovery partner, Sygnature Discovery (“Sygnature”) has announced its acquisition of one of North America’s largest discovery Contract Research Organisations, Canada-based NuChem Sciences. This acquisition cements Sygnature as one of the world’s largest players in integrated drug discovery phase solutions and advances their vision to become the global market leader.

Titian Software enters a 3-year agreement with leading life science company

Titian Software LTD and Evotec have signed a 3-year agreement to expand their collaboration around Titian Software’s Mosaic Sample Management Platform.

Expert Speaker Lineup Revealed for Award Winning RBQM Event

Expert Speaker Lineup Revealed for Award Winning RBQM Event Full agenda and keynote speakers announced for industry-leading risk-based quality management event focusing on the global transformation and evolution of RBQM, sponsored by CluePoints.

EmendoBio Scientists Participate in National Neutropenia Network Patient Retreat

Scientists attend national patient retreat and share scientific updates on investigational EMD-101 for severe congenital neutropenia treatment

The Portrait Project gives clinical trial patients a platform to share their unique experiences and influence change

The Portrait Project gives clinical trial patients a platform to share their unique experiences and influence change Clinical trial participants, caregivers and health professionals share unfiltered accounts of their personal health journeys and provide insights into their experience in clinical trials.

DNAnexus and BigOmics Analytics Join Forces to Improve Proteomics and Transcriptomics Data Visualization and Interpretation

DNAnexus announced a collaboration with BigOmics Analytics to provide customers with a fully integrated solution to better understand large-scale proteomics and transcriptomics data.